Director of Managed Care

Posted on 5/22/2024



11-50 employees

Personalized AI tests for prostate cancer


Remote in USA

Required Skills
  • Minimum of 5 years of experience in private payer reimbursement within the US healthcare system with a focus on laboratory testing.
  • Extensive background in precision diagnostic laboratories with proprietary products, ideally within companies offering proprietary cancer precision medicine tests.
  • Demonstrated success in negotiating contracts and securing private payer coverage for innovative healthcare solutions.
  • Familiarity with key figures in the private payer landscape and knowledge of private payer decision-making dynamics
  • Experience managing teams and driving results in a fast-paced environment.
  • Excellent communication, negotiation, and interpersonal skills.
  • Ability to travel as needed to support business objectives.
  • Develop and execute strategies to secure private payer coverage and contracts for Artera's precision diagnostic products.
  • Cultivate and maintain relationships with key stakeholders at private payer organizations, including executives, medical directors, and reimbursement decision-makers.
  • Drive negotiations with private payers to establish favorable coverage terms and reimbursement rates for Artera's proprietary products.
  • Conduct thorough market analysis to identify opportunities for expansion and growth within targeted geographic areas.
  • Ensure compliance with all regulatory requirements and payer guidelines in contract negotiations and reimbursement practices.
  • Collaborate with internal teams, including sales, marketing, compliance, billing, and regulatory affairs, to align reimbursement strategies with overall business objectives.
  • Develop and implement metrics to track the success of reimbursement efforts and adjust strategies as needed to meet organizational goals.
  • Stay abreast of industry trends, regulatory changes, and competitor activities related to private payer reimbursement and managed care.

ArteraAI offers a personalized AI-enabled test for localized prostate cancer, utilizing multimodal artificial intelligence models to predict treatment benefit and prognosis by analyzing digital pathology images and clinical data. The technology is developed using five Phase III randomized trials to provide individualized treatment plans and support shared decision-making between clinicians and patients.

Company Stage

Series C

Total Funding



Los Altos, California



Growth & Insights

6 month growth


1 year growth


2 year growth